Related Experiment Video
Updated: Jun 21, 2026

A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.
Published on: February 14, 2021
Biomaterials and Noncoding RNA: The "Repair-Alliance" Perspective in Intervertebral Disc Degeneration
Chen Liu1,2, Zhengguang Li3, Yongbo Zhang1,2
1Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, P. R. China.
Intervertebral disc degeneration (IVDD) treatments need improvement. Combining biomaterials with noncoding RNA (ncRNA) offers a promising strategy for repairing degenerated discs and enhancing patient outcomes.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Molecular Biology
Background:
- Intervertebral disc degeneration (IVDD) causes chronic back pain and functional impairment, significantly impacting quality of life.
- Current treatments offer symptomatic relief but fail to address the underlying pathology of IVDD.
- There is a critical need for novel therapies that can regenerate degenerated discs at a mechanistic level.
Purpose of the Study:
- To review the physiological and pathological features of IVDD.
- To evaluate the limitations of existing IVDD therapies.
- To explore recent advancements in biomaterials and noncoding RNA (ncRNA) for IVDD treatment.
Main Methods:
- Review of current literature on IVDD, biomaterials, and ncRNA.
- Analysis of how biomaterials can mimic the native extracellular matrix (ECM) and deliver bioactive molecules.
- Investigation of ncRNA's role in regulating IVDD pathogenesis and its potential in gene therapy.
Main Results:
- Biomaterials show potential in supporting disc structure and promoting tissue regeneration.
- ncRNAs regulate key genes involved in IVDD, offering a target for gene therapy.
- Nanoparticle-based delivery systems are being developed for targeted ncRNA delivery to degenerated discs.
Conclusions:
- Combining biomaterials with ncRNA delivery presents a synergistic approach for IVDD treatment.
- Multifunctional biomaterial platforms are needed to provide structural support and targeted gene therapy.
- Future research should focus on developing these platforms to improve disc regeneration and clinical outcomes for IVDD patients.
Related Concept Videos
Long-patch Base Excision Repair
Fixing Double-strand Breaks
Overview of Regeneration and Repair
Regeneration
All animals have varying degrees of...
Herniated Intervertebral Disc l: Introduction
Degenerative Disc Disease I: Introduction
Degenerative Disc Disease ll: Pathophysiology

